Literature DB >> 20139634

Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing's syndrome.

Satoru Sakihara1, Kazunori Kageyama, Yutaka Oki, Masaru Doi, Yasumasa Iwasaki, Shinobu Takayasu, Takako Moriyama, Ken Terui, Takeshi Nigawara, Yukio Hirata, Kozo Hashimoto, Toshihiro Suda.   

Abstract

As a screening test for Cushing's syndrome, the evaluation of late-night cortisol levels is indispensable. We evaluated the usefulness and accuracy of plasma, urinary, and salivary cortisol levels measured late at night for the diagnosis of Cushing's syndrome. High cortisol levels (> 5 microg/dL) during the night are indicative of Cushing's syndrome, although night plasma cortisol levels are not readily reproducible because of the stressful situation. There was no correlation between plasma and urinary cortisol levels late at night, and late-night urinary cortisol levels provided weak information for the diagnosis of Cushing's syndrome. By contrast, late-night plasma and salivary cortisol levels showed a positive correlation, and salivary cortisol sampling was found to be useful for the diagnosis of Cushing's syndrome, because more than 0.4 microg/dL of late-night salivary cortisol levels gave a sensitivity of 86% and a specificity of 100% in our hospital. This method is also useful for the diagnosis of early or mild stage Cushing's syndrome, so-called subclinical Cushing's syndrome. Inherent differences between assays make it difficult to define optimal diagnostic criteria. However, the relative levels of salivary cortisol ratio, which is presented as a relative level, compared with the mean levels of healthy subjects in each institute, is useful for the screening of Cushing's syndrome as the cut-off level of 1.5 shows both high sensitivity and specificity in subclinical and overt Cushing's syndrome. Late-night salivary cortisol measurement is therefore a primary method of choice in the screening of patients suspected of having Cushing's syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139634     DOI: 10.1507/endocrj.k09e-340

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  5 in total

1.  Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.

Authors:  C A Carrasco; M García; M Goycoolea; J Cerda; J Bertherat; O Padilla; D Meza; N Wohllk; T Quiroga
Journal:  Endocrine       Date:  2012-01-24       Impact factor: 3.633

2.  Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.

Authors:  Zhanna E Belaya; Alexander V Iljin; Galina A Melnichenko; Liudmila Y Rozhinskaya; Natalia V Dragunova; Larisa K Dzeranova; Svetlana A Butrova; Ekaterina A Troshina; Ivan I Dedov
Journal:  Endocrine       Date:  2012-03-25       Impact factor: 3.633

Review 3.  Cushing's syndrome: diagnosis and surveillance using salivary cortisol.

Authors:  Hershel Raff
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

4.  A pilot study of the effects of suboccipital fascial release on cortisol levels in workers in the clothing industry - randomized clinical trial.

Authors:  Bruna Luísa Silva; Lara Alves de Oliveira; Camila Medeiros Costa; Cristiano Queiroz Guimarães; Leonardo Sette Vieira; Andrei Pereira Pernambuco
Journal:  J Can Chiropr Assoc       Date:  2020-08

5.  Midnight salivary cortisol for the diagnosis of Cushing's syndrome in a Chinese population.

Authors:  Dao-Chen Lin; Pei-Shan Tsai; Yi-Chun Lin
Journal:  Singapore Med J       Date:  2018-11-29       Impact factor: 1.858

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.